North America Microcrystalline Cellulose Market to Reach USD 1,058.00 Million by 2032, Growing at 7.4% CAGR: Polaris Market Research

According to a new report by Polaris Market Research, the North America microcrystalline cellulose market was valued at USD 556.74 million in 2023 and is projected to reach USD 1,058.00 million by 2032, expanding at a CAGR of 7.4% over the forecast period (2024–2032). Growth is underpinned by rising demand from the pharmaceutical industry, expanding personal care and cosmetics applications, and growing consumer preference for natural and sustainable ingredients across end-use industries.

What Is Driving North America Microcrystalline Cellulose Market Growth?

Demand is climbing as the expanding pharmaceutical industry converges with rising personal care and cosmetics innovation. Manufacturers and formulators are prioritizing clean and green beauty ingredients, pushing microcrystalline cellulose (MCC) adoption as a texturizing, bulking, and stabilizing agent across the United States and Canada. Polaris analysts note that over 300 active U.S. drug shortages were reported in 2023 alone, positioning MCC a key tablet disintegrant, binder, and filler for sustained growth through 2032, with the pharmaceutical segment emerging as the largest revenue contributor and cosmetics & personal care posting strong incremental gains.

Key Trends Shaping the North America Microcrystalline Cellulose Industry

Rising Personal Care and Cosmetics Demand

Microcrystalline cellulose serves as a texturizing and bulking agent that improves the consistency of creams, lotions, and solid cosmetic formulations, while its natural, non-toxic origin appeals to formulators pursuing clean and green beauty claims. In November 2022, the SOFW Journal reported that MCC positively impacts the sensory profile and texture of solid foundation formulations, reinforcing its role as a 100% plant-based alternative to microplastics in personal care products.

Growing Pharmaceutical Industry

As a widely used excipient, MCC functions as a disintegrant, binder, and filler in tablet production, and demand is rising alongside an aging population and increasing chronic disease prevalence. In October 2023, Roquette introduced three new excipient grades including MICROCEL 113 SD and MICROCEL 103 SD designed for moisture-sensitive active pharmaceutical and nutraceutical ingredients, reflecting continued product innovation in this segment.

Supply Collaboration and Product Innovation

Key players are forming partnerships to expand formulator access to MCC excipients and reduce impurity risk. In November 2023, BASF Pharma Solutions and IFF Pharma Solutions launched a collaboration on the ZoomLab platform for IFF's Avicel microcrystalline cellulose, while Asahi Kasei introduced a low-nitrite Ceolus MCC grade in February 2024 aimed at reducing nitrosamine impurity risk in pharmaceuticals and nutritional supplements.

👉 Explore The Complete Comprehensive Report Here: https://www.polarismarketresearch.com/industry-analysis/north-america-microcrystalline-cellulose-market

Market Segmentation: Breaking Down the North America Microcrystalline Cellulose Market

Polaris segments the North America microcrystalline cellulose market by source type, end use, and country, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Source Type

The wood-based segment accounted for a significant market share in 2023, supported by high purity, consistent quality, and well-established wood pulp refining infrastructure. Manufacturers have optimized extraction and refinement processes to enhance product quality and reduce production costs, with companies such as BASF Pharma Solutions and IFF Pharma Solutions collaborating to expand formulator access to wood-based MCC excipients like Avicel.

By End Use

The pharmaceutical segment held the largest share in 2023, underpinned by advanced healthcare infrastructure supporting extensive research, development, and production activity. Food and beverages, cosmetics & personal care, and paints and coatings round out the remaining end-use categories, with cosmetics & personal care gaining traction on rising demand for natural and vegan formulations.

By Country

The United States led the North America market in 2023, driven by rising demand across the pharmaceutical, cosmetics, and food & beverages industries alongside growing consumer preference for processed and functional foods. Canada held a significant market share as well, supported by its growing pharmaceutical industry and manufacturers such as Silverline Chemicals expanding local MCC production capabilities.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the North America microcrystalline cellulose market, this report benchmarks market share, segment-level trends, and forecast data by source type, end use, and country to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing excipient suppliers, investors sizing entry points, and strategy teams tracking clean-label cosmetics and nutraceutical formulation as growth adjacencies.

👉 Explore the Full North America Microcrystalline Cellulose Market Report: https://www.polarismarketresearch.com/industry-analysis/north-america-microcrystalline-cellulose-market

Competitive Landscape: Leading North America Microcrystalline Cellulose Companies

Key players profiled in the report include ANDRITZ, Apollo Scientific Ltd, Asahi Kasei Corporation, Azelis, DFE Pharma, FMC Corporation, International Flavors & Fragrances Inc. (IFF), JRS PHARMA, Roquette Frères, and SEPPIC, who are focusing on research and development, product innovation, and strategic collaborations to strengthen market position across the pharmaceutical and wood-based segments outlined above. Recent moves include IFF's September 2023 showcase of its low-nitrite Avicel PH LN portfolio for pharmaceutical applications and DFE Pharma's July 2021 launch of Pharmacol sMCC 90, a silicified MCC solution for challenging oral solid dosage formulations, both aimed at deepening share in the North American market.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Pulmonary Arterial Hypertension Market

Coalescing Agents Market

Artificial Intelligence in Cancer Diagnostics Market

Cell & Gene Therapy Bioanalytical Testing Services Market

Coalescing Agents Market

Platelet Rich Plasma (PRP) Market

Nanopatterning Market

Canola Oil Market: A Healthy Option for Detrimental Diseases

Plasmid DNA Manufacturing Market